SAP announced its intent to take Qualtrics public in the United States

By Nikita Chaurasia  Date: 2020-07-27

SAP announced its intent to take Qualtrics public in the United States

SAP SE, a German multinational software corporation, has reportedly announced to take Qualtrics, a developer of experience management (XM) solutions, public through an IPO in the United States. Sources state that SAP accounts for 100% shares and will remain as a major stakeholder in Qualtrics following the IPO.

For those uninitiated, Washington-based Qualtrics is a part of SAP’s cloud portfolio and has operated with greater autonomy as compared to the other acquired companies

As per credible sources, primary objective of SAP for the public offering is to strengthen Qualtrics’ ability to acquire its complete potential in Experience Management. This will further increase Qualtrics’ autonomy and will also promote its expansion within SAP’s customer base.

Sources with the knowledge of the matter state that SAP recognized the potential of Qualtrics and had acquired it just four days prior to going public in 2018. SAP is apparently committed to Qualtrics’s Experience Management platform and will remain as a key element to its intelligent enterprise strategy.

Qualtrics Founder Ryan Smith was reported saying that SAP is a favorable partner with unmatched global reach, and the company is thrilled to continue the partnership, which will allow for developing the XM ecosystem for a broader array of partners.

In this context, SAP CEO Christian Klein stated that an IPO would provide the greatest opportunity for Qualtrics to expand the Experience Management category in order to serve its customers, continue building the best talent, and explore its own acquisition strategy.

Christian further claimed that SAP will remain as Qualtrics’ most important market as well as research and development (R&D) partner while enabling the latter in greater freedom in its individual expansion.

However, a final decision on the IPO, its conditions and timings are yet to be confirmed and is further subjected to market conditions, sources claimed.

Source-

https://news.sap.com/2020/07/sap-announces-intent-qualtrics-ipo/

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

By Nikita Chaurasia

Motorola Solutions has announced to have been selected by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to offer the Norwegian Health Emergency Service with a new CRS (Command Central Control Room Solution). Confirming the news,&...

Nestle India exploring options to directly sell products to consumers

Nestle India exploring options to directly sell products to consumers

By Nikita Chaurasia

Nestle India Ltd. is reportedly exploring their options of trying their hands at direct selling since consumers are largely turning towards the internet to purchase products ranging from staples to medicines amidst the COVID-19 pandemic. While the n...

Razorpay: New funding en route, meteoric rise in market value expected

Razorpay: New funding en route, meteoric rise in market value expected

By Nikita Chaurasia

Indian startup Razorpay is reportedly in discussions with Singapore-based sovereign wealth fund GIC Pvt. Ltd. and other existing investors to raise around USD 200 million in a funding round that would allow the fintech company to double its valuation...

FDA to allow pharma companies modify COVID-19 shots amid variants surge

FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the dise...

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

By Nikita Chaurasia

China-based leading pharmaceutical organization Gan & Lee Pharmaceuticals Co. Ltd. has announced to have signed a strategic collaboration with the International Diabetes Federation (IDF) to bolster its efforts towards promoting the prevention and...